8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jun 15, 2026 · 15d ago · Accession 0001636282-26-000083
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K
- Filing date
- Jun 15, 2026
- Report date
- Jun 15, 2026
- Document
- syre-20260615.htm
- Size
- 215 KB